Antibiotic-induced release of endotoxin. A therapeutic paradox
- PMID: 7619330
- DOI: 10.2165/00002018-199512030-00004
Antibiotic-induced release of endotoxin. A therapeutic paradox
Abstract
There is clear experimental evidence that antibiotics increase the bioavailability of endotoxin from Gram-negative bacteria. In this review, data for 2 variables, level of endotoxin and level of bacteria, at the time point closest to 2 hours post-antibiotic exposure were abstracted as a change from baseline readings from each available study, to enable presentation in a graphical overview. This overview indicates that the phenomenon is not limited to beta-lactam agents nor is it apparent only for the more rapidly bactericidal agents. However, evidence that this phenomenon is of clinical importance is scant. With the Jarisch-Herxheimer reaction (JHR), there is clear evidence for an acute deterioration with the initiation of antibiotic therapy and yet uncertainty as to the nature of the bacterial mediator(s) of this reaction. There is no evidence to support the commonly stated concern that therapy with antibiotics with a more rapid bactericidal action may result in the sudden lysis of bacteria with the release of cell wall components and cause a deterioration that might be avoidable through the use of antibiotics with a slower time course of action.
Similar articles
-
Antibiotic-induced release of endotoxin: a reappraisal.Clin Infect Dis. 1992 Nov;15(5):840-54. doi: 10.1093/clind/15.5.840. Clin Infect Dis. 1992. PMID: 1445982 Review.
-
Antibiotic induced endotoxin release and clinical sepsis: a review.J Chemother. 2001 Nov;13 Spec No 1(1):159-72. doi: 10.1179/joc.2001.13.Supplement-2.159. J Chemother. 2001. PMID: 11936361 Review.
-
Clinical implications of antibiotic-induced endotoxin release in septic shock.Intensive Care Med. 2002 Jul;28(7):824-33. doi: 10.1007/s00134-002-1330-6. Epub 2002 May 30. Intensive Care Med. 2002. PMID: 12122518 Review.
-
Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.Scand J Infect Dis Suppl. 1996;101:3-8. Scand J Infect Dis Suppl. 1996. PMID: 9060044 Review.
-
Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis.Scand J Infect Dis Suppl. 1996;101:9-13. Scand J Infect Dis Suppl. 1996. PMID: 9060045 Review.
Cited by
-
Fc-modified HIT-like monoclonal antibody as a novel treatment for sepsis.Blood. 2020 Mar 5;135(10):743-754. doi: 10.1182/blood.2019002329. Blood. 2020. PMID: 31722003 Free PMC article.
-
Retargeting R-type pyocins to generate novel bactericidal protein complexes.Appl Environ Microbiol. 2008 Jun;74(12):3868-76. doi: 10.1128/AEM.00141-08. Epub 2008 Apr 25. Appl Environ Microbiol. 2008. PMID: 18441117 Free PMC article.
-
Immunostimulation in the era of the metagenome.Cell Mol Immunol. 2011 May;8(3):213-25. doi: 10.1038/cmi.2010.77. Epub 2011 Jan 31. Cell Mol Immunol. 2011. PMID: 21278764 Free PMC article. Review.
-
Comparison of Microbial Sampling Sites and Donor-Related Factors on Corneal Graft Contamination.J Clin Med. 2022 Oct 22;11(21):6236. doi: 10.3390/jcm11216236. J Clin Med. 2022. PMID: 36362464 Free PMC article.
-
Structural correlates of antibacterial and membrane-permeabilizing activities in acylpolyamines.Antimicrob Agents Chemother. 2006 Mar;50(3):852-61. doi: 10.1128/AAC.50.3.852-861.2006. Antimicrob Agents Chemother. 2006. PMID: 16495242 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical